IndiaOne Finance - Company Dashboard

Governance Classic Home

Gland Pharma LtdPharmaceuticalsINE068V01023Consolidated₹2961.90+51.25 (+1.76%)Jun-26

Valuation

Market Cap₹48.86K Cr

TTM PE43.23x

Forward PE38.73x

PEG4.38

Book Value₹627.91

P/B4.72x

TTM EPS₹68.51

Fwd EPS₹76.48

TTM Revenue₹6.73K Cr

TTM PAT₹1.13K Cr

TTM EBITDA₹1.75K Cr

TTM EBIT₹1.32K Cr

Last Qtr PAT₹316.96 Cr

Last Qtr EBITDA₹489.37 Cr

Last Qtr EBIT₹378.11 Cr

Profitability

ROE10.90%

ROCE15.16%

TTM NPM16.78%

TTM EBITDA %26.04%

Curr OPM17.03%

Last OPM19.78%

Curr NPM—

Last NPM—

Curr EPS₹19.23

Last EPS₹22.26

Balance sheet

Equity₹16.48 Cr

Reserve₹10.34K Cr

Total Debt₹283.60 Cr

D/E0.03x

Interest %1.38%

Curr Interest₹4.36 Cr

Price / range

Close₹2961.90

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+1.86%

1W+1.34%

1M+3.60%

3M+34.57%

6M+78.06%

1Y+46.82%

2Y+60.77%

3Y+74.61%

5Y—

Diwali+72.68%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	36.45	14.50%
DIVISLAB	9375.00	₹2.49L Cr	85.06	17.45%
TORNTPHARM	4840.00	₹1.84L Cr	77.32	25.70%
ZYDUSLIFE	1160.00	₹1.16L Cr	25.85	16.94%
CIPLA	1394.50	₹1.13L Cr	33.41	9.75%
LAURUSLABS	1954.00	₹1.06L Cr	96.45	20.58%
AUROPHARMA	1734.00	₹99.77K Cr	27.09	9.79%
DRREDDY	1185.00	₹98.91K Cr	30.63	8.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	1,286.64+23.9%	1,261.59	1,177.51	1,074.15	1,038.84	4,552.09
Other Income	58.82	106.36	60.21	82.59	54.74	303.90
Total Income	1,345.46+23.0%	1,367.95	1,237.72	1,156.74	1,093.58	4,855.99
Interest	0.69	6.17	0.50	3.97	7.44	18.07
Expenditure	-857.77-17.3%	-803.15	-800.92	-748.07	-731.19	-3,083.33
PBDT	0	0	0	0	0	0
EBITDA	473.51+31.9%	507.72	421.62	374.89	358.86	1,663.07
Depreciation	-43.95	-43.11	-44.53	-44.84	-43.77	-176.24
EBIT	429.56+36.3%	464.61	377.09	330.05	315.09	1,486.83
PBT	487.69+34.6%	564.80	412.46	408.67	362.38	1,748.31
Tax	-123.30	-144.35	-104.61	-106.68	-93.13	-448.76
Equity	16.50	16.48	16.48	0	16.48	16.48
OPM	36.25	41.29	33.32	38.05	33.14	36.00
Net Profit	364.39+35.3%	420.45	307.85	302	269.26	1,299.55
NPM	27.08	30.74	24.87	28.11	24.62	26.76
EPS	22.11+35.3%	25.52	18.68	18.33	16.34	78.88

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23
Revenue	4,552.09+10.6%	4,116.15-1.2%	4,167.43+15.2%	3,616.53
Other Income	303.90	215.08	166.67	240.46
Total Income	4,855.99+12.1%	4,331.22-0.1%	4,334.09+12.4%	3,856.99
Expenditure	-3,083.33-7.6%	-2,865.64+2.1%	-2,928.60-6.4%	-2,752.13
Interest	-18.07	-22.84	-7.84	-7.41
PBDT	0	0	0	0
EBITDA	1,663.07+15.3%	1,442.62+2.4%	1,408.78+38.3%	1,018.55
Depreciation	-176.24	-169.27	-162.11	-146.74
EBIT	1,486.83+16.8%	1,273.35+2.1%	1,246.67+43.0%	871.81
PBT	1,748.31+19.3%	1,465.59+4.3%	1,405.50+34.1%	1,048.40
Tax	-448.76	-375.83	-362.17	-272.58
Equity	16.48	16.48	0	0
OPM (%)	36.00	33.84	32.00	27.00
Net Profit	1,299.55+19.3%	1,089.75+4.4%	1,043.33+34.5%	775.83
NPM (%)	26.76	25.16	24.00	20.00
EPS (Rs)	78.88+19.2%	66.15+4.4%	63.35+34.4%	47.12
CEPS	78.78	66.15	63.33	47.11

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	1,800.27+19.6%	1,742.79	1,695.36	1,486.88	1,505.62	6,430.65
Other Income	61.23	111.47	63.17	84.16	57.53	316.33
Total Income	1,861.50+19.1%	1,854.26	1,758.54	1,571.04	1,563.15	6,746.98
Interest	4.36	10.03	3.93	7.82	11.50	33.28
Expenditure	-1,426.52-14.1%	-1,348.46	-1,372.06	-1,287.12	-1,250.41	-5,258.05
PBDT	0	0	0	0	0	0
EBITDA	489.37+33.1%	513.02	434.88	313.89	367.76	1,629.55
Depreciation	-111.26	-108.66	-107.65	-106.31	-101.05	-423.67
EBIT	378.11+41.8%	404.36	327.23	207.58	266.71	1,205.88
PBT	434.98+39.1%	505.80	362.13	283.92	312.74	1,464.58
Tax	-118.02	-139.12	-100.65	-100.23	-97.26	-437.26
Equity	16.50	16.48	0	0	16.48	16.48
OPM	23.37	27.28	20.59	18.07	20.01	21.71
Net Profit	316.96+47.1%	366.68	261.48	183.68	215.48	1,027.32
NPM	17.03	19.78	14.87	11.69	13.78	15.23
EPS	19.23+47.0%	22.26	15.87	11.15	13.08	62.35

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23
Revenue	6,430.65+14.5%	5,616.50-0.9%	5,664.72+56.3%	3,624.60
Other Income	316.33	213.61	170.24	240.46
Total Income	6,746.98+15.7%	5,830.11-0.1%	5,834.96+51.0%	3,865.06
Expenditure	-5,258.05-10.3%	-4,767.45-1.4%	-4,702.42-70.7%	-2,754.02
Interest	-33.28	-42	-26.20	-7.45
PBDT	0	0	0	0
EBITDA	1,629.55+28.4%	1,268.92-4.8%	1,333.07+30.1%	1,024.77
Depreciation	-423.67	-377.87	-344.57	-146.74
EBIT	1,205.88+35.3%	891.05-9.9%	988.50+12.6%	878.03
PBT	1,464.58+37.8%	1,062.66-6.2%	1,132.54+7.4%	1,054.58
Tax	-437.26	-364.13	-360.08	-273.54
Equity	16.48	16.48	0	0
OPM (%)	21.71	18.23	19.41	27.28
Net Profit	1,027.32+47.1%	698.53-9.6%	772.46-1.1%	781.04
NPM (%)	15.23	11.98	13.24	20.21
EPS (Rs)	62.35+47.1%	42.40-9.6%	46.90-1.1%	47.44
CEPS	62.28	42.40	46.89	47.43

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2026	Final Dividend	20	11 Aug 2026
2025	Final Dividend	18	14 Aug 2025
2024	Final Dividend	20	16 Aug 2024

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split